The program is designed with a novel, liver-detargeting, muscle-tropic capsid intended to improve safety and ...

Investigational Treatment Regimen Could Expand Options for Virologically Suppressed Adults –– Positive Phase 3 Results from ...

WASHINGTON, D.C. / ACCESS Newswire / December 15, 2025 / Leading national organizations have come together to form the Alliance to Strengthen America's Health Workforce for the Underserved, a ...

The "Botulinum Toxin in Urology Market Outlook 2026-2034: Market Share and Growth Analysis" has been added to ResearchAndMarkets.com's offering.The Botulinum Toxin in Urology Market is valued at USD 1 ...

NeoGenomics moving toward a full U.S. clinical launch of its RaDaR ST molecular residual disease (MRD) assay in Q1 2026FORT ...

The global drug-device combination products market is projected to experience a compound annual growth rate (CAGR) of ...

FutureWise Research, a leading provider of strategic market intelligence, has published an in-depth new market analysis ...

OrganaBio, LLC, a leading provider of human research- and clinical-grade cellular starting materials and clinical trial support services today announced the opening of its newest cell processing and ...

The "Tourette Syndrome Drugs Market Outlook 2026-2034: Market Share, and Growth Analysis" has been added to ResearchAndMarkets.com's offering.The Tourette Syndrome Drugs Market is projected to witness ...

OlivePoint Capital (“OlivePoint”), an institutional real estate investment manager focused on thematic and special situations strategies, and Redwood Capital Management, LLC, a global alternative ...

Matrix One, a leading digital solution provider for the medical devices and life sciences industry and backed by Lauxera Capital Partners, announces today the acquisition of dokspot GmbH, a pioneering ...

Ophidion, Inc., a biotechnology company pioneering non-invasive delivery of gene-silencing and large-molecule therapeutics to the brain, and Neuronasal, Inc., a clinical-stage company advancing ...